CDEK
← All trials

NCT01332968

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jul 31, 2011
Primary completion
Jan 31, 2016
Completion date
Aug 31, 2021
First posted
—
Last posted
—
Enrollment
1401
Arms / groups
2 / —
Source
AACT · pre-existing

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.